DOJ Moves Forward on Cannabis Schedule III Reclassification
Department of Justice advances marijuana rescheduling process following Trump's executive directive, bringing federal cannabis reform closer to reality.
The Department of Justice has officially begun implementing the federal reclassification of marijuana from Schedule I to Schedule III of the Controlled Substances Act, following President Trump's executive order issued over four months ago. Acting Attorney General Todd Blanche now oversees the completion of this regulatory shift that could fundamentally reshape the cannabis industry's operating environment.
The rescheduling represents the most substantial federal cannabis reform in decades, potentially unlocking significant tax advantages for cannabis operators currently barred from standard business deductions under Section 280E. Multi-state operators like Curaleaf (CURLF), Trulieve (TCNNF), and Green Thumb Industries (GTBIF) stand to benefit dramatically from improved cash flows once the reclassification takes effect, as companies could deduct ordinary business expenses currently prohibited under Schedule I classification.
Beyond tax implications, Schedule III status opens pathways for increased institutional investment and banking services that have remained largely inaccessible to cannabis companies. The reclassification also removes barriers to interstate commerce and could accelerate FDA approval processes for cannabis-derived pharmaceuticals, creating new revenue streams for companies with medical cannabis research programs.
The timeline acceleration under the Trump administration contrasts sharply with the prolonged review process that characterized previous federal cannabis policy discussions. This decisive regulatory action signals a more business-friendly approach that prioritizes industry growth over continued prohibition, potentially catalyzing consolidation activity as companies position for expanded market access.
Investors should monitor implementation details closely, as the operational changes required for Schedule III compliance will create both opportunities and challenges. Companies with strong compliance infrastructure and diversified product portfolios are best positioned to capitalize on the expanded federal framework, while smaller operators may face pressure to scale or seek acquisition partners to compete in the evolving regulatory landscape.